| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody–Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review
|
Rossi, Cédric
|
|
2018
|
13 |
3 |
p. 287-308
|
artikel
|
| 2 |
Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma
|
Yamamoto, Kazuhiro
|
|
2018
|
13 |
3 |
p. 371-378
|
artikel
|
| 3 |
Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer
|
Blair, Hannah A.
|
|
2018
|
13 |
3 |
p. 399-407
|
artikel
|
| 4 |
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies
|
Barata, Pedro C.
|
|
2018
|
13 |
3 |
p. 353-361
|
artikel
|
| 5 |
Avelumab: A Review in Metastatic Merkel Cell Carcinoma
|
Shirley, Matt
|
|
2018
|
13 |
3 |
p. 409-416
|
artikel
|
| 6 |
Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer
|
Kim, Dong Ha
|
|
2018
|
13 |
3 |
p. 389-398
|
artikel
|
| 7 |
Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease
|
Hochmair, Maximilian
|
|
2018
|
13 |
3 |
p. 269-285
|
artikel
|
| 8 |
Prognostic and Predictive Factors for Renal Cell Carcinoma
|
Suárez, Cristina
|
|
2018
|
13 |
3 |
p. 309-331
|
artikel
|
| 9 |
Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma
|
Ikeda, Takashi
|
|
2018
|
13 |
3 |
p. 379-387
|
artikel
|
| 10 |
Targeting BCL-2 in Hematologic Malignancies
|
Khan, Nadia
|
|
2018
|
13 |
3 |
p. 257-267
|
artikel
|
| 11 |
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study
|
Knapen, Lotte M.
|
|
2018
|
13 |
3 |
p. 363-370
|
artikel
|
| 12 |
The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
|
Nichetti, Federico
|
|
2018
|
13 |
3 |
p. 333-351
|
artikel
|
Tijdschrift beschrijving